<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20100211003329N9</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2022-10-22</date_registration>
      <primary_sponsor>Kashan University of Medical Sciences</primary_sponsor>
      <public_title>The effect of ear acupressure (Auriculotherapy) on Persistent Fatigue in patients recovered from the acute phase of COVID-19 disease</public_title>
      <acronym></acronym>
      <scientific_title>The effect of ear acupressure (Auriculotherapy) on Persistent Fatigue in patients recovered from the acute phase of COVID-19 disease</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2022-10-23</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>52</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/65296</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment, Randomization description: The selected eligible samples will be randomly assigned to each of the two groups (intervention and control) in the form of randomization in the form of 4 and 6 blocks randomization. Using the Sealed Envelope Ltd software. 2017 Available Through www.sealedenvelope.com 7 block of 4 and 4 block of 6, overall 11 blocks were defined that the allocation to groups would be based on the order specified by the software, Blinding description: Participants and outcome assessors are unaware of the nature of the seeds pasted on participants' ears.</study_design>
      <phase>N/A</phase>
      <hc_freetext>COVID-19.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: In the intervention group, the researcher will stick Seed Vaccaria brand ZHONG YANG, made in China,  on 6 points related to fatigue, including: Nervous Subcortex, Sympathetic Point, Shen Men, Point Zero, Master Cerebral Point, Anti-Depressant and the patient will be taught to press the points using the thumb and forefinger for four weeks, five days a week, two times a day and 60 times each time. It should be noted that during the 4 weeks of the intervention, Vaccaria seeds will be stuck alternately on both ears by the researcher every week, after cleaning the skin with alcohol cotton. Seeds will be placed on the ears five days a week and the patient will be asked to remove the adhesives at the end of the fifth day to prevent possible allergic reaction. The patient will be instructed to contact the researcher if the adhesives are separated during the five-day period so that the researcher will stuck the adhesives in the agreed place. During the intervention, a diary sheet will be given to the person every week, in which the number of times of pressure, the occurrence of allergic reactions and taking a new drug will be specified. The contents of the daily note sheet are organized using pictorial symbols in such a way that it can be understood and completed by all samples, both literate and illiterate, with simple training. During the intervention period, every week all the participants will be visited at the agreed place and new seeds will be stuck to their ears, and a daily note sheet will be taken from them and another sheet will be given to them for the next week. If in the intervention group, the average number of daily pressures on the seeds during each week of the intervention is less than 60 times, that person will be excluded from the study. Sticking the seeds will continue for 4 weeks and the samples will be followed up 4 weeks after the end of the intervention. The 11- question form of Chalder Fatigue Score with a 4-point Likert scoring style of 0 to 3 will be completed at the beginning of the study, after the end of the intervention and 4 weeks after the end of the intervention for two groups through an interview with the individual by colleague that is not aware of assigning samples to groups. At the time of sampling, the phone number and home address of the samples will be recorded, and during the intervention period, at the end of each week, also for the purpose of follow-up 4 weeks after the end of the intervention, regarding the time and place of the visit and if necessary, the device There will be coordinated with them by phone. Intervention 2: Control group: the adhesives will be stuck to the points of the Nervous Subcortex, Sympathetic Point, Shen Men, Point Zero, Master Cerebral Point, Anti-Depressant without Seed, and no pressure  will be applied  on them. It should be noted that during the 4 weeks of the intervention, non- seed adhesives in the control group will be glued by the researcher alternately on both ears every week after cleaning the skin with alcohol cotton. Seeds will be placed on the ears five days a week and the patient will be asked to remove the adhesives at the end of the fifth day to prevent possible allergic reaction. The patient will be taught to contact the researcher if the adhesives are detached during the five-day period so that the adhesives will be stuck by the researcher at the agreed place.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>No - There is not a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for not sharing IPD is En Not done yet</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Zahra Tagharrobi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Kashan University of Medical Sciences, Pezeshk Blvd, Qutb Rawandi Blvd, Kashan</address>
        <city>Kashan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>8715981151</zip>
        <telephone>+98 31 5510 3119</telephone>
        <email>tagharrobi_z@yahoo.com</email>
        <affiliation>Kashan University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Zahra Tagharrobi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Kashan University of Medical Sciences, Pezeshk Blvd, Ghotb Ravandi Blvd, Kashan</address>
        <city>kashan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>8715981151</zip>
        <telephone>+98 31 5510 3119</telephone>
        <email>tagharrobi_z@yahoo.com</email>
        <affiliation>Kashan University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Get a minimum score of 4  from the Chalder Fatigue Scale with bimodal scoring
At least 6 weeks have passed since the onset of symptoms based on the record
Having a positive PCR for Covid-19 based on the record
Consent to participate in the study
Age range 18-65 years
Iranian citizenship
Resident in Kashan
Body mass index less than 40
Organ health in the earlobe area
Treatment and discontinuation, only with the doctor's order</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>65 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Re-hospitalization during the period of covid disease
Suffering from known underlying diseases (anemia, psychiatric disorders, mental retardation, thyroid disorders, multiple sclerosis, chronic heart or lung disease, cancer and hypotension, etc.)
Pregnancy and breastfeeding according to patient report
Suffering from covid complications such as thromboembolism based on the contents of the record
Connecting to a ventilator during hospitalization based on the contents of the record
Skin sensitivity to alcohol and glue according to patient report
Using acupuncture and acupressure within the last 3 months
taking medication
Consumption of cigarettes, alcohol or drugs according to patient report</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>U09.9</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Post COVID-19 condition, unspecified</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Drugs</i_code>
      <i_code>Placebo</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: In the intervention group, the researcher will stick Seed Vaccaria brand ZHONG YANG, made in China,  on 6 points related to fatigue, including: Nervous Subcortex, Sympathetic Point, Shen Men, Point Zero, Master Cerebral Point, Anti-Depressant and the patient will be taught to press the points using the thumb and forefinger for four weeks, five days a week, two times a day and 60 times each time. It should be noted that during the 4 weeks of the intervention, Vaccaria seeds will be stuck alternately on both ears by the researcher every week, after cleaning the skin with alcohol cotton. Seeds will be placed on the ears five days a week and the patient will be asked to remove the adhesives at the end of the fifth day to prevent possible allergic reaction. The patient will be instructed to contact the researcher if the adhesives are separated during the five-day period so that the researcher will stuck the adhesives in the agreed place. During the intervention, a diary sheet will be given to the person every week, in which the number of times of pressure, the occurrence of allergic reactions and taking a new drug will be specified. The contents of the daily note sheet are organized using pictorial symbols in such a way that it can be understood and completed by all samples, both literate and illiterate, with simple training. During the intervention period, every week all the participants will be visited at the agreed place and new seeds will be stuck to their ears, and a daily note sheet will be taken from them and another sheet will be given to them for the next week. If in the intervention group, the average number of daily pressures on the seeds during each week of the intervention is less than 60 times, that person will be excluded from the study. Sticking the seeds will continue for 4 weeks and the samples will be followed up 4 weeks after the end of the intervention. The 11- question form of Chalder Fatigue Score with a 4-point Likert scoring style of 0 to 3 will be completed at the beginning of the study, after the end of the intervention and 4 weeks after the end of the intervention for two groups through an interview with the individual by colleague that is not aware of assigning samples to groups. At the time of sampling, the phone number and home address of the samples will be recorded, and during the intervention period, at the end of each week, also for the purpose of follow-up 4 weeks after the end of the intervention, regarding the time and place of the visit and if necessary, the device There will be coordinated with them by phone.</i_keyword>
      <i_keyword>Control group: the adhesives will be stuck to the points of the Nervous Subcortex, Sympathetic Point, Shen Men, Point Zero, Master Cerebral Point, Anti-Depressant without Seed, and no pressure  will be applied  on them. It should be noted that during the 4 weeks of the intervention, non- seed adhesives in the control group will be glued by the researcher alternately on both ears every week after cleaning the skin with alcohol cotton. Seeds will be placed on the ears five days a week and the patient will be asked to remove the adhesives at the end of the fifth day to prevent possible allergic reaction. The patient will be taught to contact the researcher if the adhesives are detached during the five-day period so that the adhesives will be stuck by the researcher at the agreed place.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Persistent Fatigue score. Timepoint: Before the intervention, 4 weeks after the beginning of the intervention, 4 weeks after the end of the intervention. Method of measurement: Chalder Fatigue Questionnaire.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Allergy to seed. Timepoint: weekely. Method of measurement: Report of patient.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Kashan University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2022-09-11</approval_date>
        <contact_name>Research Ethics Committees of Faculty of Medicine &amp; Faculty of Dentistry- Kashan University of Medic</contact_name>
        <contact_address>Kashan University of Medical Sciences, Pezeshk Blvd, Qutb Rawandi Blvd, Kashan Kashan Isfehan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
